Trial Outcomes & Findings for Clinical Evaluation of the Efficacy of a Marketed Dentifrice on Plaque and Gingivitis (NCT NCT03214406)

NCT ID: NCT03214406

Last Updated: 2021-05-11

Results Overview

change in score as measured by Gingival Index (0=absence of inflammation, 1=mild inflammation: slight change in color, little change in texture of any portion of but not the entire marginal or papillary gingival unit, 2=mild inflammation: slight change in color, little change in texture to entire marginal or papillary gingival unit, 3=moderate inflammation: glazing, redness, edema and/or hypertrophy of the marginal or papillary gingival unit, 4=severe inflammation: marked redness, edema and/or hypertrophy of the marginal or papillary gingival unit, spontaneous bleeding, congestion, or ulceration. The scale ranges from 0-4.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

181 participants

Primary outcome timeframe

16 weeks

Results posted on

2021-05-11

Participant Flow

Participant milestones

Participant milestones
Measure
Arm & Hammer Advance White Brilliant Sparkle (Test Product)
2X daily brushing for 12 weeks with Arm \& Hammer Advance White Brilliant Sparkle (Test product) Arm \& Hammer Advance White Brilliant Sparkle (Test product): 20% sodium bicarbonate
Crest Cavity Protection Regular Toothpaste (Negative Control)
2X daily brushing for 12 weeks with Crest Cavity Protection Regular Toothpaste (Negative Control) Crest Cavity Protection Regular Toothpaste (Negative Control): Negative control
Overall Study
STARTED
88
93
Overall Study
COMPLETED
78
78
Overall Study
NOT COMPLETED
10
15

Reasons for withdrawal

Reasons for withdrawal
Measure
Arm & Hammer Advance White Brilliant Sparkle (Test Product)
2X daily brushing for 12 weeks with Arm \& Hammer Advance White Brilliant Sparkle (Test product) Arm \& Hammer Advance White Brilliant Sparkle (Test product): 20% sodium bicarbonate
Crest Cavity Protection Regular Toothpaste (Negative Control)
2X daily brushing for 12 weeks with Crest Cavity Protection Regular Toothpaste (Negative Control) Crest Cavity Protection Regular Toothpaste (Negative Control): Negative control
Overall Study
did not meet enrollment criteria
9
13
Overall Study
Withdrawal by Subject
1
0
Overall Study
Lost to Follow-up
0
2

Baseline Characteristics

Race and Ethnicity were not collected from any participant.

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Arm & Hammer Advance White Brilliant Sparkle (Test Product)
n=78 Participants
2X daily brushing for 12 weeks with Arm \& Hammer Advance White Brilliant Sparkle (Test product) Arm \& Hammer Advance White Brilliant Sparkle (Test product): 20% sodium bicarbonate
Crest Cavity Protection Regular Toothpaste (Negative Control)
n=78 Participants
2X daily brushing for 12 weeks with Crest Cavity Protection Regular Toothpaste (Negative Control) Crest Cavity Protection Regular Toothpaste (Negative Control): Negative control
Total
n=156 Participants
Total of all reporting groups
Age, Categorical
<=18 years
0 Participants
n=78 Participants
0 Participants
n=78 Participants
0 Participants
n=156 Participants
Age, Categorical
Between 18 and 65 years
78 Participants
n=78 Participants
78 Participants
n=78 Participants
156 Participants
n=156 Participants
Age, Categorical
>=65 years
0 Participants
n=78 Participants
0 Participants
n=78 Participants
0 Participants
n=156 Participants
Sex: Female, Male
Female
56 Participants
n=78 Participants
51 Participants
n=78 Participants
107 Participants
n=156 Participants
Sex: Female, Male
Male
22 Participants
n=78 Participants
27 Participants
n=78 Participants
49 Participants
n=156 Participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Gingvial Efficacy
2.039 units on a scale
STANDARD_DEVIATION .053 • n=78 Participants
2.039 units on a scale
STANDARD_DEVIATION .057 • n=78 Participants
2.039 units on a scale
STANDARD_DEVIATION .055 • n=156 Participants
Gingival Bleeding Efficacy
.228 units on a scale
STANDARD_DEVIATION .046 • n=78 Participants
.230 units on a scale
STANDARD_DEVIATION .044 • n=78 Participants
.229 units on a scale
STANDARD_DEVIATION .045 • n=156 Participants
Plaque Efficacy
2.575 units on a scale
STANDARD_DEVIATION .295 • n=78 Participants
2.534 units on a scale
STANDARD_DEVIATION .248 • n=78 Participants
2.555 units on a scale
STANDARD_DEVIATION .272 • n=156 Participants

PRIMARY outcome

Timeframe: 16 weeks

change in score as measured by Gingival Index (0=absence of inflammation, 1=mild inflammation: slight change in color, little change in texture of any portion of but not the entire marginal or papillary gingival unit, 2=mild inflammation: slight change in color, little change in texture to entire marginal or papillary gingival unit, 3=moderate inflammation: glazing, redness, edema and/or hypertrophy of the marginal or papillary gingival unit, 4=severe inflammation: marked redness, edema and/or hypertrophy of the marginal or papillary gingival unit, spontaneous bleeding, congestion, or ulceration. The scale ranges from 0-4.

Outcome measures

Outcome measures
Measure
Arm & Hammer Advance White Brilliant Sparkle (Test Product)
n=78 Participants
2X daily brushing for 12 weeks with Arm \& Hammer Advance White Brilliant Sparkle (Test product) Arm \& Hammer Advance White Brilliant Sparkle (Test product): 20% sodium bicarbonate
Crest Cavity Protection Regular Toothpaste (Negative Control)
n=78 Participants
2X daily brushing for 12 weeks with Crest Cavity Protection Regular Toothpaste (Negative Control) Crest Cavity Protection Regular Toothpaste (Negative Control): Negative control
Within-Treatment Whole-Mouth Differences (vs Baseline) - Gingival Efficacy
4 weeks
.230 units on a scale
Standard Deviation .105
.155 units on a scale
Standard Deviation .123
Within-Treatment Whole-Mouth Differences (vs Baseline) - Gingival Efficacy
8 weeks
.3701 units on a scale
Standard Deviation .130
.205 units on a scale
Standard Deviation .077
Within-Treatment Whole-Mouth Differences (vs Baseline) - Gingival Efficacy
12 weeks
.444 units on a scale
Standard Deviation .139
.214 units on a scale
Standard Deviation .110
Within-Treatment Whole-Mouth Differences (vs Baseline) - Gingival Efficacy
16 weeks
.330 units on a scale
Standard Deviation .118
.157 units on a scale
Standard Deviation .084

PRIMARY outcome

Timeframe: 16 weeks

change in score as measured by Gingival Bleeding Index (0=absence of bleeding after 30 seconds, 1= bleeding observed after 30 seconds, 2= bleeding occurs instantly). The scale ranges from 0-2.

Outcome measures

Outcome measures
Measure
Arm & Hammer Advance White Brilliant Sparkle (Test Product)
n=78 Participants
2X daily brushing for 12 weeks with Arm \& Hammer Advance White Brilliant Sparkle (Test product) Arm \& Hammer Advance White Brilliant Sparkle (Test product): 20% sodium bicarbonate
Crest Cavity Protection Regular Toothpaste (Negative Control)
n=78 Participants
2X daily brushing for 12 weeks with Crest Cavity Protection Regular Toothpaste (Negative Control) Crest Cavity Protection Regular Toothpaste (Negative Control): Negative control
Within-Treatment Whole-Mouth Differences (vs Baseline) Gingival Bleeding Efficacy
4 weeks
.134 units on a scale
Standard Deviation .055
.119 units on a scale
Standard Deviation .056
Within-Treatment Whole-Mouth Differences (vs Baseline) Gingival Bleeding Efficacy
8 weeks
.162 units on a scale
Standard Deviation .042
.145 units on a scale
Standard Deviation .039
Within-Treatment Whole-Mouth Differences (vs Baseline) Gingival Bleeding Efficacy
12 weeks
.190 units on a scale
Standard Deviation .045
.162 units on a scale
Standard Deviation .056
Within-Treatment Whole-Mouth Differences (vs Baseline) Gingival Bleeding Efficacy
16 weeks
.180 units on a scale
Standard Deviation .043
.144 units on a scale
Standard Deviation .056

PRIMARY outcome

Timeframe: 16 weeks

change in score as measured by Plaque Index (0=no visible plaque, 1=separate flecks of plaque at the cervical margin of the tooth, 2=a thin, continuous band of plaque (up to 1mm wide) at the cervical margin, 3= a band of plaque wider than 1 mm but covering less than one-third of the crown, 4=plaque covering at least one-third but less than two-thirds of the crown, 5= plaque covering two-thirds or more of the crown. The scale ranges from 0-5.

Outcome measures

Outcome measures
Measure
Arm & Hammer Advance White Brilliant Sparkle (Test Product)
n=78 Participants
2X daily brushing for 12 weeks with Arm \& Hammer Advance White Brilliant Sparkle (Test product) Arm \& Hammer Advance White Brilliant Sparkle (Test product): 20% sodium bicarbonate
Crest Cavity Protection Regular Toothpaste (Negative Control)
n=78 Participants
2X daily brushing for 12 weeks with Crest Cavity Protection Regular Toothpaste (Negative Control) Crest Cavity Protection Regular Toothpaste (Negative Control): Negative control
Within-Treatment Whole-Mouth Differences (vs Baseline) - Plaque Efficacy
4 weeks
.648 units on a scale
Standard Deviation .327
.468 units on a scale
Standard Deviation .264
Within-Treatment Whole-Mouth Differences (vs Baseline) - Plaque Efficacy
8 weeks
.776 units on a scale
Standard Deviation .369
.574 units on a scale
Standard Deviation .283
Within-Treatment Whole-Mouth Differences (vs Baseline) - Plaque Efficacy
12 weeks
.765 units on a scale
Standard Deviation .295
.533 units on a scale
Standard Deviation .332
Within-Treatment Whole-Mouth Differences (vs Baseline) - Plaque Efficacy
16 weeks
.275 units on a scale
Standard Deviation .378
.275 units on a scale
Standard Deviation .378

Adverse Events

Arm & Hammer Advance White Brilliant Sparkle (Test Product)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Crest Cavity Protection Regular Toothpaste (Negative Control)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Annahita Ghassemi

Church & Dwight Co., Inc

Phone: 6098061200

Results disclosure agreements

  • Principal investigator is a sponsor employee Confidentiality agreement in place with Investigator.
  • Publication restrictions are in place

Restriction type: OTHER